SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-19-005152
Filing Date
2019-08-13
Accepted
2019-08-12 18:42:33
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 h73019010q.htm 10-Q 386982
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 41139
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 266306
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 53801
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 8691
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 8752
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 4715
8 EXHIBIT 32.2 ex32_2.htm EX-32.2 4687
  Complete submission text file 0001214659-19-005152.txt   2833324

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE hgen-20190630.xml EX-101.INS 336196
10 XBRL SCHEMA FILE hgen-20190630.xsd EX-101.SCH 41354
11 XBRL CALCULATION FILE hgen-20190630_cal.xml EX-101.CAL 37304
12 XBRL DEFINITION FILE hgen-20190630_def.xml EX-101.DEF 132712
13 XBRL LABEL FILE hgen-20190630_lab.xml EX-101.LAB 281289
14 XBRL PRESENTATION FILE hgen-20190630_pre.xml EX-101.PRE 200507
Mailing Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 191017901
SIC: 2834 Pharmaceutical Preparations